EZH2 and diffuse large B-cell lymphoma: Mutations in EZH2 and CREBBP are also enriched in GCB-DLBCL (12 and 16%) compared with all DLBCL cases (6 vs. 11%, respectively) (Pasqualucci et al., 2011a; Reddy et al., 2017).